Sensitive ASX Announcement

Preliminary results in Clinuvel's Phase III porphyria trial

Published: 21/12/09, 10:47am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only